The DOI matches its Crossref record; 45 of the 48 references it cites were found in a registry or an index.
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Open accessAbstract
p53 has a key role in the negative regulation of cell proliferation, in the maintenance of genomic stability, and in the suppression of transformation and tumorigenesis. To identify novel regulators of p53, we undertook two functional screens to isolate genes which bypassed either p53-mediated growth arrest or apoptosis. In both screens, we isolated cDNAs encoding macrophage migration inhibitory factor (MIF), a cytokine that was shown previously to exert both local and systemic proinflammatory activities. Treatment with MIF overcame p53 activity in three different biological assays, and suppressed its activity as a transcriptional activator. The observation that a proinflammatory cytokine, MIF, is capable of functionally inactivating a tumor suppressor, p53, may provide a link between inflammation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity33.”
From Inflammation and cancer (2002) · cites this paper as [33]
In the citing paper
“tetracycline regulated expression of wild-type p53 (GFP tagged) in the TGP53-4 mouse cell line (27) caused a significant decline in endogenous PGM activity (Fig. 5B).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J. D., Xie, Q. W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,245
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“the tetracycline inducible system (22), and pBabe-puro-tet-GFP-”
Research works printed but not linked: 1
- Christen, 1999, Chronic infection and inflammation lead to cancer
Cited by
Sorted by citations
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,960
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature reviews. Immunology · doi:10.1038/nri1200 · Cited by 1,782
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1252 · Cited by 1,660
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,049
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
T he P athogenesis of O ral L ichen P lanus
Sugerman, P. B., Savage, N. W., Walsh, L. J., Zhao, Z. Z., Zhou, X. J., Khan, A., Seymour, G. J., & Bigby, M. E. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300405 · Cited by 780
Candido, J., & Hagemann, T. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9847-0 · Cited by 759
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.020 · Cited by 679
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Self-citationInflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., & Bucala, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 622
Chronic immune activation and inflammation as the cause of malignancy
O'Byrne, K. J., & Dalgleish, A. G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1943 · Cited by 546
Stark, K., Eckart, A., Haidari, S., Tirniceriu, A., Lorenz, M., von Brühl, M.-L., Gärtner, F., Khandoga, A. G., Legate, K. R., Pless, R., et al. (2013) · Nature Immunology · doi:10.1038/ni.2477 · Cited by 447
Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
Thomas, R., Wang, W., & Su, D.-M. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-0173-8 · Cited by 442
A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1
Wang, Y., An, R., Umanah, G. K., Park, H., Nambiar, K., Eacker, S. M., Kim, B., Bao, L., Harraz, M. M., Chang, C., et al. (2016) · Science · doi:10.1126/science.aad6872 · Cited by 421
Ursolic acid: An anti‐ and pro‐inflammatory triterpenoid
Ikeda, Y., Murakami, A., & Ohigashi, H. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700389 · Cited by 418
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 417
Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., & Bernhagen, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210318 · Cited by 385
Coussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 382
Migratory neighbors and distant invaders: tumor-associated niche cellsPreprint
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. C. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 392
Fehniger, T. A., Suzuki, K., Ponnappan, A., VanDeusen, J. B., Cooper, M. A., Florea, S. M., Freud, A. G., Robinson, M. L., Durbin, J. E., & Caligiuri, M. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.219 · Cited by 373
Baugh, J. A., Chitnis, S., Donnelly, S. C., Monteiro, J., Lin, X., Plant, B. J., Wolfe, F., Gregersen, P. K., & Bucala, R. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363867 · Cited by 360
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Lue, H., Kleemann, R., Calandra, T., Roger, T., & Bernhagen, J. (2002) · Microbes and infection · doi:10.1016/s1286-4579(02)01560-5 · Cited by 394
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Morand, E. F., Leech, M. T., & Bernhagen, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2029 · Cited by 348
p53, cancer and the immune response
Blagih, J., Buck, M. D., & Vousden, K. H. (2020) · Journal of Cell Science · doi:10.1242/jcs.237453 · Cited by 333
Macrophage migration inhibitory factor
Baugh, J. A., & Bucala, R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00004 · Cited by 342
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Landi, S., Moreno, V. R., Gioia‐Patricola, L., Guinó, E., Navarro, M., de, J., Capellá, G., & Canzian, F. (2003) · PubMed · Cited by 314
Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B. P., Mitchell, R. A., Lolis, E., & Al‐Abed, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203220200 · Cited by 306
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared
Rhodes, J. M., & Campbell, B. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02194-3 · Cited by 299
Interplay between inflammation and cancer
Khandia, R., & Munjal, A. K. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.09.004 · Cited by 300
Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., & Shachar, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703265200 · Cited by 291
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S. C., Lam, W. L., & Bennewith, K. L. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 295
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting
Fingerle‐Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R. A., Huss, R., Moll, U. M., Müller, W., & Bucala, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533295100 · Cited by 284
Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 287
Meyer‐Siegler, K. L., Iczkowski, K. A., Leng, L., Bucala, R., & Vera, P. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8730 · Cited by 261
Flaster, H. V., Bernhagen, J., Calandra, T., & Bucala, R. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0065 · Cited by 262
Evolving complexity of MIF signaling
Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S., & Boor, P. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.006 · Cited by 246
Macrophage migration inhibitory factor (MIF): A promising biomarker
Grieb, G., Merk, M., Bernhagen, J., & Bucala, R. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.4.1453629 · Cited by 246
Oral lichen planus: Causes, diagnosis and management
Sugerman, P. B., & Sabage, N. (2002) · Australian Dental Journal · doi:10.1111/j.1834-7819.2002.tb00540.x · Cited by 236
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
Stein, R., Mattes, M. J., Cardillo, T. M., Hansen, H. J., Chang, C., Burton, J., Govindan, S. V., & Goldenberg, D. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1167 · Cited by 228
Bowel Inflammation as Measured by Fecal Calprotectin
Poullis, A. P., Foster, F., Shetty, A., Fagerhol, M. K., & Mendall, M. A. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0160 · Cited by 224
Mignogna, M. D., Fedele, S., Russo, L. L., Muzio, L. L., & Bucci, E. (2003) · Oral Oncology · doi:10.1016/j.oraloncology.2003.08.001 · Cited by 220
Differential gene expression profiling in human brain tumors
Markert, J. M., Fuller, C. M., Gillespie, G. Y., Bubien, J. K., McLean, L. A., Hong, R. L., Lee, K., Gullans, S. R., Mapstone, T. B., & Benos, D. J. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.1.21 · Cited by 219
Rei, M., Gonçalves‐Sousa, N., Lança, T., Thompson, R. G., Mensurado, S., Balkwill, F. R., Kulbe, H., Pennington, D. J., & Silva‐Santos, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403424111 · Cited by 217
Simpson, K. D., Templeton, D. J., & Cross, J. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201161 · Cited by 218
Macrophage Migration Inhibitory Factor: A Probable Link between Inflammation and Cancer
Bucala, R., & Donnelly, S. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.005 · Cited by 210
Inflammation and p53: A Tale of Two Stresses
Gudkov, A. V., Gurova, K. V., & Komarova, E. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409747 · Cited by 211
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link
Conroy, H., Mawhinney, L., & Donnelly, S. C. (2010) · QJM · doi:10.1093/qjmed/hcq148 · Cited by 202
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 213
Avis, I. M., Hong, S. H., Martı́nez, A., Moody, T. W., Choi, Y. H., Trepel, J. B., Das, R., Jett, M., & Mulshine, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0866fje · Cited by 201
Nishihira, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050151012 · Cited by 196
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
O’Reilly, C., Doroudian, M., Mawhinney, L., & Donnelly, S. C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21385 · Cited by 182
Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications
Najafi, M., Motevaseli, E., Shirazi, A., Geraily, G., Rezaeyan, A., Norouzi, F., Rezapoor, S., & Abdollahi, H. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1440092 · Cited by 192
Krockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S. F., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 180
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Merk, M., Mitchell, R. A., Endres, S., & Bucala, R. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.014 · Cited by 178
Tumors are unique organs defined by abnormal signaling and context
Radisky, D. C., Hagios, C., & Bissell, M. J. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0360 · Cited by 182
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)
Mitchell, R. A., & Bucala, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0328 · Cited by 176
Méresse, S., Fodil, M., Fleury, F., & Chénais, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239273 · Cited by 177
Mishra, A., Liu, S., Sams, G. H., Curphey, D. P., Santhanam, R., Rush, L. J., Schaefer, D. M. W., Falkenberg, L. G., Sullivan, L., Jaroncyk, L., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.009 · Cited by 172
Senter, P. D., Al‐Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J. A., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011569399 · Cited by 169
The role of microRNAs in colorectal cancer
Liu, M., & Chen, H. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60053-9 · Cited by 165
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair
Farr, L., Ghosh, S., & Moonah, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01273 · Cited by 166
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
Dalgleish, A. G., & O'Byrne, K. J. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166
HIF1α delays premature senescence through the activation of MIFPreprint
Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Powell, M. B., & Giaccia, A. J. (2006) · Genes & Development · doi:10.1101/gad.1471106 · Cited by 163
miRNA regulation of cytokine genes
Asirvatham, A. J., Magner, W. J., & Tomasi, T. B. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.010 · Cited by 168
At the Crossroads of Inflammation and Tumorigenesis
Cordon‐Cardo, C., & Prives, C. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1367 · Cited by 160
HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes
Guimarães‐Camboa, N., Stowe, J. C., Aneas, I., Sakabe, N. J., Cattaneo, P., Henderson, L. M., Kilberg, M. S., Johnson, R. S., Chen, J., McCulloch, A. D., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.04.021 · Cited by 151
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease
O’Connor, P. M. J., Lapointe, T. K., Beck, P. L., & Buret, A. G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21217 · Cited by 151
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
Verjans, E., Noetzel, E., Bektas, N., Schütz, A. K., Lue, H., Lennartz, B., Hartmann, A., Dahl, E., & Bernhagen, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-230 · Cited by 151
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
Wilson, J. M., Coletta, P. L., Cuthbert, R. J., Scott, N. A., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J. B., Jin, K. K., Lolis, E., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.061 · Cited by 146
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 146
Inflammation, carcinogenesis and cancer
Fitzpatrick, F. A. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00102-3 · Cited by 146
Fingerle-Rowson, G., Kaleswarapu, D. R., Schlander, C., Kabgani, N., Brocks, T., Reinart, N., Busch, R. M., Schütz, A. K., Lue, H., Du, X., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01907-08 · Cited by 145
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 144
Apoptosis in cancer—implications for therapy
Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 146
Vennervald, B. J., & Polman, K. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01163.x · Cited by 142
Regulation of Joint Destruction and Inflammation by p53 in Collagen-Induced Arthritis
Yamanishi, Y., Boyle, D. L., Pinkoski, M. J., Mahboubi, A., Lin, T., Han, Z., Zvaifler, N. J., Green, D. R., & Firestein, G. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64356-8 · Cited by 142
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Chen, L., Zhou, X., Fan, L. X., Yao, Y., Swenson-Fields, K. I., Gadjeva, M. G., Wallace, D. P., Peters, D. J. M., Yu, A. S. L., Grantham, J. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80467 · Cited by 139
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer
Xu, X., Wang, B., Ye, C., Chen, Y., Lin, Y., Huang, X., Zhang, Y., & Wang, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.028 · Cited by 139
Hagemann, T., Robinson, S. D., Thompson, R. G., Charles, K. A., Kulbe, H., & Balkwill, F. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0118 · Cited by 139
White, E. S., Flaherty, K. R., Carskadon, S. L., Brant, A., Iannettoni, M. D., Yee, J., Orringer, M. B., & Arenberg, D. A. (2003) · PubMed · Cited by 140
Role of MIF in Inflammation and Tumorigenesis
Bach, J., Rinn, B., Meyer, B., Dodel, R. C., & Bacher, M. (2008) · Oncology · doi:10.1159/000155223 · Cited by 138
Ren, Y., Tsui, H., Poon, R. T. P., Ng, I. O., Li, Z., Chen, Y., Jiang, G., Lau, C. P.-Y., Yu, W., Bacher, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11287 · Cited by 138
Macrophage Migration Inhibitory Factor (MIF)
Nishihira, J., Ishibashi, T., Fukushima, T., Sun, B., Sato, Y., & Todo, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03220.x · Cited by 138
Amin, A. R. M. R., Karpowicz, P. A., Carey, T. E., Arbiser, J. L., Nahta, R., Chen, Z. G., Dong, J., Küçük, Ö., Khan, G. N., Huang, G. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.005 · Cited by 146
Leng, L., Chen, L., Fan, J., Greven, D., Arjona, A., Du, X., Austin, D., Kashgarian, M. J., Yin, Z., Huang, X. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001767 · Cited by 136
The Cytokine Macrophage Migration Inhibitory Factor Reduces Pro-Oxidative Stress-Induced Apoptosis
Nguyen, M. T., Lue, H., Kleemann, R., Thiele, M., Tolle, G., Finkelmeier, D., Wagner, E., Braun, A. B., & Bernhagen, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3337 · Cited by 136
Cui, Y. R., & Guo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111942 · Cited by 137
Signal transduction in rheumatoid arthritis
Sweeney, S. E., & Firestein, G. S. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00011 · Cited by 135
Mechanisms and effectors of MIF-dependent promotion of tumourigenesis
Mitchell, R. A. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.07.002 · Cited by 135
Regulation of Macrophage Migration Inhibitory Factor Expression by Glucocorticoids in Vivo
Fingerle‐Rowson, G., Koch, P., Bikoff, R., Lin, X., Metz, C. N., Dhabhar, F. S., Meinhardt, A., & Bucala, R. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63797-2 · Cited by 134
Metadata
- Authors
- Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H.
- Affiliations
- aUnit of Cancer Biology, Institute of Child Health, London WC1N 1EH, United Kingdom
- Centro di Riferimento Oncologico (IT)
- Cold Spring Harbor Laboratory (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-11-15
- Volume
- 190
- Issue
- 10
- Pages
- 1375-1382
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2195698
- OpenAlex
- W2110929110
- Cited by
- 649
- References
- 48
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 10 · 2022: 12 · 2021: 18 · 2020: 25 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 27 · 2015: 24 · 2014: 25 · 2013: 25 · 2012: 38
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
- Funders
- University College London
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- p53, macrophage migration inhibitory factor, inflammatory cytokines, tumor suppressor inactivation, inflammation and tumorigenesis, p53 transcriptional activation, apoptosis, cell proliferation, genome stability
- MeSH terms
- Animals, Cell Line, Chronic Disease, Fibroblasts, Inflammation, Macrophage Migration-Inhibitory Factors, Neoplasms, Nitric Oxide, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review